Urinary kidney injury molecule‑1 as an early indicator to predict contrast‑induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention
- Authors:
- Wenhua Li
- Yaren Yu
- Haiyan He
- Jing Chen
- Debin Zhang
View Affiliations
Affiliations: Department of Cardiology, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China
- Published online on: April 16, 2015 https://doi.org/10.3892/br.2015.449
-
Pages:
509-512
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
With the improvement of the skill level of coronary intervention, contrast agents are used more widely. As a result, contrast‑induced acute kidney injury (CI‑AKI) is currently the third leading cause of hospital‑acquired AKI. Traditionally, AKI is defined by measuring an increase of the serum creatinine concentration (Scr). CI‑AKI indicates impairment in renal function, which is diagnosed as an elevation in the SCr levels following intravascular injection of the contrast media. However, Scr is an insensitive indicator for detecting CI‑AKI. The present study was designed to investigate whether human urinary kidney injury molecule‑1 (KIM‑1) is an early marker to predict CI‑AKI in patients with diabetes mellitus undergoing percutaneous coronary intervention (PCI). The present study includes the general clinical data of 145 patients with diabetes mellitus who underwent PCI between March 1, 2013 and December 31, 2013. A non‑ionic, low osmolarity contrast agent was used during the present study. The Scr levels and estimated glomerular filtration rate were measured prior to and within 24 and 48 h after the injection of contrast agents. Urinary samples were collected prior to and within 2, 6, 12, 24 and 48 h after the coronary interventional procedure. Simultaneously, the urinary KIM‑1 values were measured using an ELISA kit. CI‑AKI was diagnosed as an increase of ≥0.5 mg/dl or ≥25% in Scr concentration over baseline, 24‑48 h after the procedure. In total, 19 of 145 (13.1%) patients exhibited CI‑AKI. There was a significant difference (P<0.05) between the urinary KIM‑1 levels measured 2, 6, 12, 24 and 48 h after the procedure and those prior to the procedure in the CI‑AKI group. There was no significant difference between the Scr values measured 24 h after the procedure and those prior to the procedure. Evidently, using KIM‑1 values to predict CI‑AKI was <24 h earlier compared to using Scr values. The area under the receiver operating characteristic curve of KIM‑1 24 h after the procedure was 0.856 and the 95% confidence interval of the corresponding area was 0.782‑0.929. When the pivotal point of CI‑AKI diagnosis was 6,327.755 pg/ml, the specificity was 85.7% and the sensitivity was 73.7%. Univariate analysis showed that the Scr concentration was positively correlated with the urinary KIM‑1 level during the time prior to the procedure and 24 and 48 h after the procedure. In conclusion, the urinary KIM‑1 may be a potential indicator for the early diagnosis of CI‑AKI.
View References
1
|
Caixeta A and Mehran R.: Evidence-based
management of patients undergoing PCI: contrast-induced acute
kidney injury. Catheter Cardiovasc Interv. 75 (Suppl 1):S15–S20.
2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Parfrey P: The clinical epidemiology of
contrast-induced nephropathy. Cardiovasc Intervent Radiol. 28
(Suppl 2):S3–S11. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mehran R and Nikolsky E: Contrast-induced
nephropathy: definition, epidemiology, and patients at risk. Kidney
Int. Suppl (100):S11–S15. 2006. View Article : Google Scholar
|
4
|
Odutayo A and Cherney D: Cystatin C and
acute changes in glomerular filtration rate. Clin Nephrol.
78:64–75. 2012. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Mehran R: Contrast-induced nephropathy
remains a serious complication of PCI. J Interv Cardiol.
20:236–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Tonomura Y, Tsuchiya N, Torii M and Uehara
T: Evaluation of the usefulness of urinary biomarkers for
nephrotoxicity in rats. Toxicology. 273:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Huo W, Zhang K, Nie Z, Li Q and Jin F:
Kidney injury molecule-1 (KIM-1): A novel kidney-specific injury
molecule playing potential double-edged functions in kidney injury.
Transplant Rev (Orlando). 24:143–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Malhis M, Al-Bitar S and Al-Deen Zaiat K:
The role of theophylline in prevention of radiocontrast
media-induced nephropathy. Saudi J Kidney Dis Transpl. 21:276–283.
2010.PubMed/NCBI
|
9
|
McCullough PA and Soman SS:
Contrast-induced nephropathy. Crit Care Clin. 21:261–280. 2005.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Han W K, Bailly V, Abichandani R, Thadhani
R and Bonventre JV: Kidney Injury Molecule-1 (KIM-1): A novel
biomarker for human renal proximal tubule injury. Kidney Int.
62:237–244. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Parikh CR, Abraham E, Ancukiewicz M and
Edelstein CL: Urine IL-18 is an early diagnostic marker for acute
kidney injury and predicts mortality in the intensive care unit. J
Am Soc Nephrol. 16:3046–3052. 2005. View Article : Google Scholar : PubMed/NCBI
|
13
|
Melnikov VY, Ecder T, Fantuzzi G, et al:
Impaired IL-18 processing protects caspase-1-deficient mice from
ischemic acute renal failure. J Clin Invest. 107:1145–1152. 2001.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Heyman S N, Rosen S and Rosenberger C:
Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis
of radiocontrast nephropathy. Clin J Am Soc Nephrol. 3:288–296.
2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Katzberg RW: Contrast medium-induced
nephrotoxicity: Which pathway? Radiology. 235:752–755. 2005.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Bailly V, Zhang Z, Meier W, et al:
Shedding of kidney injury molecule-1, a putative adhesion protein
involved in renal regeneration. J Biol Chem. 277:39739–39748. 2002.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Vaidya VS, Ramirez V, Ichimura T, et al:
Urinary kidney injury molecule-1: A sensitive quantitative
biomarker for early detection of kidney tubular injury. Am J
Physiol Renal Physiol. 290:F517–F529. 2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ichimura T, Bonventre J V, Bailly V, et
al: Kidney injury molecule-1 (KIM-1), a putative epithelial cell
adhesion molecule containing a novel immunoglobulin domain, is
up-regulated in renal cells after injury. J Biol Chem.
273:4135–4142. 1998. View Article : Google Scholar : PubMed/NCBI
|
19
|
Thomsen HS: How to avoid CIN: guidelines
from the European Society of Urogenital Radiology. Nephrol Dial
Transplant. 20 (Suppl 1):i18–i22. 2005. View Article : Google Scholar : PubMed/NCBI
|